A recent study suggests that people who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise programs.
Published data in a prominent medical journal shows that while overweight individuals often shed a large proportion of their total mass while on the medication, the weight is regained at an estimated rate of nearly a kilo each month once they quit.
"Individuals buying such drugs must be aware of the danger of quick rebound weight gain when the therapy ends," stated researcher Dr. Susan Jebb.
That rate of regain suggests a reversion to pre-treatment mass within about one and a half years.
Analyzing Therapies
The analysis, which examined dozens of trials involving thousands of patients, compared the effects of the injectable medications with older methods.
The team emphasize that people who shed pounds through dieting usually see a less rapid weight regain—approximately 100 grams monthly—after stopping.
Explaining the Fast Regain
Doctors suggest the mechanism of the injections accounts for the heightened rebound.
These medications mimic a natural hormone called GLP-1, which moderates appetite.
"Sustained high doses of GLP-1 concentrations far above than the body's typical production might result in the system to produce less of its endogenous hormone, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this medication results in hunger is unsuppressed, making binge eating far more likely."
A Chronic Disease?
Medical guidelines recommend the jabs for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians contend that, given the high risk of weight regain, the treatment might need to be ongoing.
This opinion is echoed by pharmaceutical companies, who note that the findings "highlight the persistent character of excess weight," akin to managing conditions like diabetes.
User Experiences
People who have discontinued the medication explain a powerful return of cravings.
"It felt as if a trigger that goes on and you're instantly ravenous," said one woman.
This difficulty is compounded if individuals have not established lasting dietary or behavioural changes during treatment.
Growing Use
Survey data show that millions of people in the UK have tried these injections in the past year, with interest continuing to grow.
- Adoption is greater among women than men.
- The 40s and 50s age group shows the highest usage rates.
- Many access the medications through private healthcare rather than the NHS.
Finally, experts caution that while GLP-1 drugs are effective agents for weight loss, they are not a permanent fix and maintained weight loss likely depends on integrated lifestyle changes.
